-+ 0.00%
-+ 0.00%
-+ 0.00%

VERTEX PHARMACEUTICALS INCORPORATED : STIFEL RAISES TARGET PRICE TO $563 FROM $500

Reuters·11/03/2026 11:49:27

Please log in to view news